Viewing Study NCT02965092


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-03 @ 1:18 AM
Study NCT ID: NCT02965092
Status: UNKNOWN
Last Update Posted: 2019-05-10
First Post: 2016-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE1 View
None PHASE2 View
Observational Models:
Time Perspective List:
Who Masked List: